Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TOTAL EQUITY
Total Equity HALO - Halozyme Therapeutics, Inc.
83.8 M
LAST VALUE
-34.77%
2 YEAR CAGR
-19.56%
5 YEAR CAGR
20.00%
10 YEAR CAGR